Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Orchestra BioMed Holdings (OBIO) Leases (2022 - 2025)

Historic Leases for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $1.7 million.

  • Orchestra BioMed Holdings' Leases fell 355.89% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 355.89%. This contributed to the annual value of $2.1 million for FY2024, which is 3524.12% up from last year.
  • Latest data reveals that Orchestra BioMed Holdings reported Leases of $1.7 million as of Q3 2025, which was down 355.89% from $1.8 million recorded in Q2 2025.
  • Orchestra BioMed Holdings' Leases' 5-year high stood at $2.2 million during Q4 2022, with a 5-year trough of $1.3 million in Q2 2024.
  • For the 4-year period, Orchestra BioMed Holdings' Leases averaged around $1.8 million, with its median value being $1.8 million (2023).
  • Per our database at Business Quant, Orchestra BioMed Holdings' Leases plummeted by 2897.55% in 2024 and then skyrocketed by 3568.75% in 2025.
  • Over the past 4 years, Orchestra BioMed Holdings' Leases (Quarter) stood at $2.2 million in 2022, then decreased by 28.9% to $1.6 million in 2023, then surged by 35.24% to $2.1 million in 2024, then dropped by 21.4% to $1.7 million in 2025.
  • Its Leases stands at $1.7 million for Q3 2025, versus $1.8 million for Q2 2025 and $2.0 million for Q1 2025.